# Roche Venture Fund: portfolio, investments and team

> Roche Venture Fund is a corporate vc based in Switzerland. 57 investments on record, 1 in the last 12 months, latest Jun 2026.

Source: https://millionrounds.com/fund/roche-venture-fund (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Investor](https://millionrounds.com/investors)

# Roche Venture Fund

Last cheque observed Jun 2026; 57 cheques on record.

Email

Deploying now Corporate VC

Seed Series A Bitcoin Cryptocurrency Electronics

Follow Roche Venture Fund and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Froche-venture-fund)

Deploying now

**100%** of best year **1** **cheques in 12 months**, 57 on record

Since the last cheque **135** days **00** hrs **00** min **00** sec

Median round **$50M** Rounds led **1 of 57** Exits **7 from the portfolio** Mostly in **United States, 73%**

Pitch Roche Venture Fund

## Roche Venture Fund highlights

- 01 1 cheques in the last 12 months
- 02 Mostly Series B and Series A: 58% of its rounds
- 03 Led 1 rounds
- 04 7 exits from the portfolio

## What they do

> Roche Venture Fund is mentioned as a listed name, but the homepage text does not describe its activities. From their own website

- **Type:** Corporate VC (from a list, unverified)
- **Cheque size:** From $3.0M as they say
- **Stages:** Seed Series A
- **Sectors:** Bitcoin Cryptocurrency Electronics
- **Based in:** Basel, Switzerland
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **57 appearances**

- **2026** 1 round
- **Jun** **[COUR Pharma](https://millionrounds.com/company/cour-pharma)** Series B · US · Lumira Ventures **$50M** *Led*
- **2019** 2 rounds
- **Jul** **[Freenome](https://millionrounds.com/company/freenome)** Series B · US · FinSMEs **$160M** With 11 others
- **Jun** **[Purigen Biosystems](https://millionrounds.com/company/purigen-biosystems)** Series B · US · FinSMEs **$26M** With 3 others
- **2016** 2 rounds
- **Aug** **[Tioma](https://millionrounds.com/company/tioma)** Series A · US · FinSMEs **$86M** With 2 others
- **Jun** **[Omicia](https://millionrounds.com/company/omicia)** Series B · US · Businesswire **$23M** With 2 others
- **2015** 9 rounds
- **Oct** **[Minoryx Therapeutics](https://millionrounds.com/company/minoryx-therapeutics)** Series A · ES **$22M** With 6 others
- **Sept** **[AveXis](https://millionrounds.com/company/avexis)** Series D · US **$65M** With 11 others
- **Jul** **[SutroVax](https://millionrounds.com/company/sutrovax)** Series A · US **$22M** With 3 others
- **Jun** **[Stratos Genomics](https://millionrounds.com/company/stratos-genomics)** Series B · US **$15M** With 1 other
- **Mar** **[mySugr](https://millionrounds.com/company/mysugr)** Seed · AT **$4.8M** With 2 others
- **Mar** **[Macrolide Pharmaceuticals](https://millionrounds.com/company/macrolide-pharmaceuticals)** Series A · US **$22M** With 3 others
- **Feb** **[Lysosomal Therapeutics](https://millionrounds.com/company/lysosomal-therapeutics)** Series A · US **$20M** With 6 others
- **Jan** **[AveXis](https://millionrounds.com/company/avexis)** Series C · US **$10M** With 1 other
- **Jan** **[CytomX Therapeutics](https://millionrounds.com/company/cytomx-therapeutics)** Series C · US **$20M** With 3 others
- **2014** 8 rounds
- **Nov** **[Curetis](https://millionrounds.com/company/curetis)** Series B · DE **$18M** With 6 others
- **Oct** **[Aileron Therapeutics](https://millionrounds.com/company/aileron-therapeutics)** Series E · US **$33M** With 6 others
- **Sept** **[Allakos](https://millionrounds.com/company/allakos)** Series A · US **$10M** With 3 others
- **Aug** **[Allakos](https://millionrounds.com/company/allakos)** Series A · US **$25M** With 3 others
- **Jul** **[Epic Sciences](https://millionrounds.com/company/epic-sciences)** Series C · US **$30M** With 4 others
- **May** **[Stratos Genomics](https://millionrounds.com/company/stratos-genomics)** Series B · US **$10M** With 1 other
- **May** **[Lysosomal Therapeutics](https://millionrounds.com/company/lysosomal-therapeutics)** Seed · US **$4.8M** With 6 others
- **Apr** **[Alios BioPharma](https://millionrounds.com/company/alios-biopharma)** Series B · US **$41M** With 3 others
- **2013** 8 rounds
- **Nov** **[MISSION Therapeutics](https://millionrounds.com/company/mission-therapeutics)** Series B · GB · 4-traders.com **$30M** With 3 others
- **Nov** **[Aileron Therapeutics](https://millionrounds.com/company/aileron-therapeutics)** Series E · US · finsmes.com **$30M** With 5 others
- **Oct** **[Biodesy](https://millionrounds.com/company/biodesy)** Series A · US · finsmes.com **$15M** With 2 others
- **Oct** **[Opsona](https://millionrounds.com/company/opsona)** Series C · IE · finsmes.com **$3.9M** With 8 others
- **Jun** **[Horizon Discovery](https://millionrounds.com/company/horizon-discovery)** Series C · GB · horizondiscovery.com **$10M** With 11 others
- **Apr** **[Opsona](https://millionrounds.com/company/opsona)** Series C · IE · finsmes.com **$43M** With 7 others
- **Mar** **[MacuLogix](https://millionrounds.com/company/maculogix)** Series A · US · prnewswire.com **$3.6M** With 3 others
- **Jan** **[Aileron Therapeutics](https://millionrounds.com/company/aileron-therapeutics)** Series D · US · finsmes.com **$12M** With 5 others
- **2012** 5 rounds
- **Dec** **[Allakos](https://millionrounds.com/company/allakos)** Venture · US · sec.gov **$10.0M** With 4 others
- **Nov** **[Epic Sciences](https://millionrounds.com/company/epic-sciences)** Series B · US · finsmes.com **$13M** With 2 others
- **Nov** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Venture · US · phx.corporate-ir.net **$50M** With 8 others
- **Sept** **[Foundation Medicine](https://millionrounds.com/company/foundation-medicine)** Series B · US · finsmes.com **$43M** With 6 others
- **Jan** **[Horizon Discovery](https://millionrounds.com/company/horizon-discovery)** Series C · GB · onbiovc.com **$19M** With 3 others
- **2011** 4 rounds
- **Oct** **[Curetis](https://millionrounds.com/company/curetis)** Series A · DE · curetis.com **$13M** With 1 other
- **Aug** **[MISSION Therapeutics](https://millionrounds.com/company/mission-therapeutics)** Venture · GB · biospace.com **$10M** With 3 others
- **Jun** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Series D · US · phx.corporate-ir.net **$30M** With 9 others
- **Feb** **[Conatus Pharmaceuticals](https://millionrounds.com/company/conatus-pharmaceuticals)** Series B · US · pharmalive.com **$20M** With 5 others
- **2010** 4 rounds
- **Sept** **[Horizon Discovery](https://millionrounds.com/company/horizon-discovery)** Series C · GB · fis.dowjones.com **$9.8M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **45** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **7 in all**

**[Foundation Medicine](https://millionrounds.com/company/foundation-medicine)** Bought by Roche **Undisclosed** Jan 2015

**[Alios BioPharma](https://millionrounds.com/company/alios-biopharma)** Bought by [Johnson & Johnson](https://millionrounds.com/fund/johnson-and-johnson) **$1.8B** Sept 2014

**[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Bought by [Daiichi Sankyo](https://millionrounds.com/fund/daiichi-sankyo) **$410M** Sept 2014

**[Foundation Medicine](https://millionrounds.com/company/foundation-medicine)** Listed **$108M** Jul 2013

**[Conatus Pharmaceuticals](https://millionrounds.com/company/conatus-pharmaceuticals)** Listed **$69M** Jun 2013

**[HistoRx](https://millionrounds.com/company/historx)** Bought by Genoptix **Undisclosed** Sept 2012

**[Intradigm Corporation](https://millionrounds.com/company/intradigm-corporation)** Bought by [Silence Therapeutics](https://millionrounds.com/fund/silence-therapeutics) **Undisclosed** Dec 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A

Median round joined **$50M** the round, not its cheque

Led 1 of 57 rounds **2%**

- **Said size:** From $3.0M
- **Sole investor:** Never alone
- **Last cheque:** Jun 2026
- **Exits:** 7 from the portfolio

Rounds by stage said on their site

- Series B *20*
- Series A said *12*
- Series C *11*
- Series D *6*
- Series E *3*
- Venture *3*
- Seed said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 15
- [SR One](https://millionrounds.com/fund/sr-one) 8
- [Alta Partners](https://millionrounds.com/fund/alta-partners) 7
- [Forward Ventures](https://millionrounds.com/fund/forward-ventures) 6
- [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 6
- [Pfizer](https://millionrounds.com/fund/pfizer) 6

**Pitching Roche Venture Fund?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Roche Venture Fund. A count of rooms they were both in, not a relationship either has claimed.

[**Novartis Venture Fund** Corporate VC **15** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**SR One** Corporate VC **8** rounds together](https://millionrounds.com/fund/sr-one)[**Alta Partners** VC firm **7** rounds together](https://millionrounds.com/fund/alta-partners)[**Forward Ventures** Accelerator **6** rounds together](https://millionrounds.com/fund/forward-ventures)[**Novo Holdings** VC firm **6** rounds together](https://millionrounds.com/fund/novo-ventures)[**Pfizer** Corporate VC **6** rounds together](https://millionrounds.com/fund/pfizer)[**Gimv** Private equity **5** rounds together](https://millionrounds.com/fund/gimv)[**Apple Tree Partners** VC firm **4** rounds together](https://millionrounds.com/fund/apple-tree-partners)[**Astellas Venture Management** Corporate VC **4** rounds together](https://millionrounds.com/fund/astellas-venture-management)[**EQT life science** Private equity **4** rounds together](https://millionrounds.com/fund/lsp-bioventures)[**Excel Venture Management** VC firm **4** rounds together](https://millionrounds.com/fund/excel-venture-management-llc)[**Lilly Ventures** Corporate VC **4** rounds together](https://millionrounds.com/fund/lilly-ventures)

## Recently backed

The latest companies Roche Venture Fund put money into.

[**COUR Pharma** $50M · Jun 2026](https://millionrounds.com/company/cour-pharma)[**Freenome** $160M · Jul 2019](https://millionrounds.com/company/freenome)[**Purigen Biosystems** $26M · Jun 2019](https://millionrounds.com/company/purigen-biosystems)[**Omicia** $23M · Jun 2016](https://millionrounds.com/company/omicia)

## Quick answers about Roche Venture Fund

### What does Roche Venture Fund invest in?

Roche Venture Fund invests most often at Series B and Series A (58% of the rounds on record), in sectors such as Bitcoin, Cryptocurrency and Electronics.

### How active is Roche Venture Fund?

57 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Jun 2026.

### What has Roche Venture Fund invested in recently?

Its most recent investments on record: COUR Pharma (Series B, Jun 2026), Freenome (Series B, Jul 2019) and Purigen Biosystems (Series B, Jun 2019).

### How big are Roche Venture Fund's cheques?

The median round it joins is $50M.

### Does Roche Venture Fund lead rounds?

Sometimes: it led 1 of its 57 investments on record (2%).

### Where does Roche Venture Fund invest?

Most of the companies it backs are in the United States (73%), the United Kingdom (13%) and Germany (5%).

### Is Roche Venture Fund investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

### Who does Roche Venture Fund invest alongside?

Most often Novartis Venture Fund (15 rounds together), SR One (8 rounds together) and Alta Partners (7 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=roche-venture-fund) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=roche-venture-fund)